Povorcitinib Clinical Trial (STOP-HS LTE) AGE: 18+ HURLEY STAGE: All LOCATION: International View Details
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment AGE: 12+ HURLEY STAGE: I & II LOCATION: US Only View Details
A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions AGE: 18+ HURLEY STAGE: All LOCATION: US Only View Details
The Ohio State University Dermatology Biorepository AGE: 7+ HURLEY STAGE: All LOCATION: US Only View Details
A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa AGE: 18-70 HURLEY STAGE: II & III LOCATION: US Only View Details
A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa AGE: 18-70 HURLEY STAGE: II & III LOCATION: International View Details
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives AGE: 18+ HURLEY STAGE: All LOCATION: US Only View Details
HIDRAdenitis Suppurativa and HEART Disease AGE: 18+ HURLEY STAGE: All LOCATION: International View Details
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC AGE: 7+ HURLEY STAGE: All LOCATION: International View Details
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa. AGE: 18+ SEVERITY: Moderate to Severe LOCATION: International View Details
Patient’s Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation AGE: 18+ HURLEY STAGE: All LOCATION: International View Details